Health Care & Life Sciences » Pharmaceuticals | Essex Bio-Technology Ltd.

Essex Bio-Technology Ltd. | Balance Sheet

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
55
62
65
156
269
311
Total Accounts Receivable
111
161
206
258
336
475
Inventories
6
35
39
138
104
71
Other Current Assets
3
26
50
4
6
5
Total Current Assets
175
284
359
555
715
863
Net Property, Plant & Equipment
186
183
174
164
174
169
Total Investments and Advances
-
-
24
103
90
167
Long-Term Note Receivable
-
-
12
27
33
11
Intangible Assets
18
36
37
77
141
221
Other Assets
8
-
30
6
6
19
Total Assets
387
503
637
933
1,160
1,450
ST Debt & Current Portion LT Debt
51
51
51
39
29
Accounts Payable
-
-
1
2
1
Income Tax Payable
3
3
3
10
23
Other Current Liabilities
74
106
152
195
224
Total Current Liabilities
128
160
208
244
277
Long-Term Debt
-
-
-
155
162
Deferred Taxes
5
12
15
11
14
Total Liabilities
133
172
224
410
454
Common Equity (Total)
254
331
413
524
706
Total Shareholders' Equity
254
331
413
524
706
Total Equity
254
331
413
524
706
Liabilities & Shareholders' Equity
387
503
637
933
1,160

About Essex Bio-Technology

View Profile
Address
Room 2818, China Merchants Tower
Hong Kong
Hong Kong
Employees -
Website http://www.essexbio.com
Updated 07/08/2019
Essex Bio-Technology Ltd. is an investment holding company, which engages in the manufacture, development, and sale of biopharmaceutical products. It operates through the Pharmaceutical Products and Provision of Marketing Services segments. It offers products under the brand of Beifuji, Beifushu, and Beifuxin.